Tag: Elivaldogene autotemcel

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Elivaldogene autotemcel

Bluebird hits back at Roche's Spark, saying trademark lawsuit is attempt to 'silence' educational ...

Added to Collection on: 2021-07-07 14:48:45

Tags for this article:

Branches of biology
Life Sciences
Health sciences
Gene delivery
Gene therapy
Orphan drugs
Breakthrough therapy
Biotechnology
Bluebird bio
Spark Therapeutics
Elivaldogene autotemcel
Sickle-cell disease
Roche

Click the tags to see associated articles and topics

View Article Details
bluebird bio (NASDAQ:BLUE) Price Target Lowered to $35.00 at Morgan Stanley

Added to Collection on: 2021-07-16 13:11:18

Tags for this article:

Finance
Money
Economy
Stock market
Corporate finance
Valuation
Bluebird bio
Stock
Short
Securities research
Financial analyst
Elivaldogene autotemcel

Click the tags to see associated articles and topics

View Article Details
Bluebird to wind down business in Europe amid gene therapy struggles

Added to Collection on: 2021-08-09 16:41:15

Tags for this article:

Branches of biology
Biology
Clinical medicine
Gene delivery
Bluebird bio
Applied genetics
Medical genetics
Gene therapy
Breakthrough therapy
Elivaldogene autotemcel
Beta thalassemia
Sickle-cell disease

Click the tags to see associated articles and topics

View Article Details
bluebird bio Announces FDA Priority Review of Biologics License Application for eli-cel ...

Added to Collection on: 2021-12-18 14:01:42

Tags for this article:

Branches of biology
Health
Rare diseases
Breakthrough therapy
Leukodystrophies
Elivaldogene autotemcel
Gene therapy
Bluebird bio
Adrenoleukodystrophy
ABCD1
ALD
Clinical trial
Bluebird Bio Inc
Lenti-D
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Bluebird faces longer wait for FDA verdict on experimental gene therapies | BioPharma Dive

Added to Collection on: 2022-01-18 16:32:25

Tags for this article:

Branches of biology
Life Sciences
Biology
Gene therapy
Orphan drugs
Rare diseases
Biotechnology
Food and Drug Administration
Bluebird bio
Priority review
Voretigene neparvovec
Elivaldogene autotemcel

Click the tags to see associated articles and topics

View Article Details
Bluebird stock rises amid price target cut at Morgan Stanley | Seeking Alpha

Added to Collection on: 2022-05-17 18:35:33

Tags for this article:

Life Sciences
Biology
Branches of biology
Biotechnology
Gene therapy
Breakthrough therapy
Bluebird bio
Orphan drugs
Gene delivery
Elivaldogene autotemcel
Food and Drug Administration
Underweight
Getty Images

Click the tags to see associated articles and topics

View Article Details
bluebird bio (NASDAQ:BLUE) Rating Lowered to Neutral at JPMorgan Chase & Co.

Added to Collection on: 2024-08-16 03:43:54

Tags for this article:

Stock market
Bluebird bio
Elivaldogene autotemcel
Hedge fund
Stock
Berkshire Hathaway
Volume
Bluebird Bio Inc

Click the tags to see associated articles and topics

View Article Details
Analysts Set bluebird bio, Inc. (NASDAQ:BLUE) PT at $5.46 - Defense World

Added to Collection on: 2024-08-18 17:26:13

Tags for this article:

Orphan drugs
Biotechnology
Gene delivery
Stock market
Bluebird bio
Equity securities
Elivaldogene autotemcel
Betibeglogene autotemcel
Overweight
Short
Gene therapy
Share

Click the tags to see associated articles and topics

View Article Details